• Refine Query
  • Source
  • Publication year
  • to
  • Language
  • 23
  • 18
  • 15
  • 13
  • 7
  • 5
  • 4
  • 3
  • 2
  • 1
  • Tagged with
  • 97
  • 35
  • 25
  • 23
  • 19
  • 19
  • 19
  • 13
  • 13
  • 13
  • 11
  • 9
  • 9
  • 8
  • 8
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
21

Effects of siRNA-squalene nanoparticles on RET/PTCs junction oncogenes in papillary thyroid carcinoma : from molecular and cellular studies to preclinical investigations / Effets des nanoparticules de siRNA-Squalène sur les oncogènes de jonction RET/PTCs dans le carcinome papillaire de la thyroïde : études moléculaires, cellulaires et investigations précliniques

Ali, Hafiz Muhammad 22 April 2014 (has links)
Le cancer papillaire de la thyroïde (PTC) est celui le plus fréquent de la thyroïde. Il est caractérisé par des réarrangements chromosomique affectant le gène RET, dont les plus fréquemment observés sont RET/PTC1 et RET/PTC3. Les oncogène de jonction sont spécifiques à la tumeur et représentent une cible privilégiée pour une thérapie ciblée par des petits ARN interférents (siRNA). Notre but est d’introduire une nouvelle approche pharmacologique par siRNA pour les PTC. Pour réaliser nos expériences, la lignée cellulaire humaine PTC, BHP10-3 SCmice exprimant l’oncogène RET/PTC1 a été utilisé. En absence de lignée RET/PTC3 commercialisée nous avons établi la lignée cellulaire RP3 (stablement transfecté la lignée NIH/3T3 issue de fibroblastes de souris par un vecteur d’expression RET/PTC3) qui s’est avérée tumorigène chez la souris. Ensuite, des siRNAs dirigés contre la jonction ont été dessinés. Les siRNAs ont été trouvés efficaces et spécifiques contre leurs propres oncogènes de jonction et ne sont pas capables d'inhiber l'expression de séquences alternées. Les siRNAs ont été vectorisés sous forme de nanoparticules (NPs) de squalène (SQ). In vitro, les NPs siRNA RET/PTC1-SQ et NPs siRNA RET/PTC3-SQ sont incapables d’inhiber l’expression de l’oncogène et l’oncoprotéine sauf transfectés par lipofectamine. Pour cela, un peptide, le GALA-Chol a été combiné aux NPs siRNA RET/PTC1-SQ ce qui les a rendu efficace in vitro dans l’inhibition de l’oncogène et de l’oncoprotéine mais inefficace sur la croissance tumorale in vivo probablement par agrégation des NPs siRNA RET/PTC1-SQ GALA-Chol dans la circulation sanguine. En revanche les NPs siRNA RET/PTC1-SQ (0.5mg/kg/souris) et NPs siRNA RET/PTC3-SQ (2.5mg/kg/souris) sont efficaces in vivo, ils inhibent considérablement la croissance tumorale, réduisent l’expression des oncogènes et des oncoprotéines RET/PTCs, induisent la mort cellulaire par clivage de la caspase-3 et de PARP-1 et restaurent partiellement la différenciation (diminution de marqueur Ki67). Ces résultats suggèrent l'utilisation des NPs siRNAs-SQ en tant que traitement pour les patients atteints de PTC exprimant les oncogènes de jonctions RET/PTCs. / Papillary thyroid carcinoma (PTC) is the most common of thyroid cancers. PTC is characterized by chromosomal rearrangements affecting chromosome 10 and leading to RET/PTC junction oncogenes. The most frequent ones are RET/PTC1 and RET/PTC3. Because the junction oncogenes are present only in the tumour cells, they represent a good target for a specific therapy such as small interfering RNA (siRNA). Our aim is to introduce a new pharmacological approach by siRNA for PTC. To perform the experiments, human BHP10-3 SCmice cell line expressing RET/PTC1 was used. Due to absence of commercially available RET/PTC3 cell line, we established a new RP3 cell line (from NIH/3T3 mouse fibroblasts, transfected stably with the RET/PTC3 expression vector) which was found to become tumorigenic in nude mice. siRNAs were designed within the junction sequences of both RET/PTC1 and RET/PTC3. Both siRNAs were found efficient and specific against their own junction oncogenes and were not able to inhibit the expression of alternate sequences. Then, siRNAs were vectorized in the form of nanoparticles (NPs) of squalene (SQ). In vitro, both siRNA RET/PTC1-SQ NPs and siRNA RET/PTC3-SQ NPs were found to be inefficient in gene and protein inhibitions except once transfected with lipofectamine. Therefore, a peptide GALA-Chol was added in siRNA RET/PTC1-SQ NPs which rendered them efficient in vitro in gene and protein inhibitions but found to be inefficient in vivo. The nanoparticles of siRNA RET/PTC1-SQ NPs (0.5 mg/kg/mouse) and siRNA RET/PTC3-SQ NPs (2.5 mg/kg/mouse) were found to drastically reduce the tumor growth and RET/PTCs oncogene and oncoprotein expressions. Moreover, they induced cell death by cleavage of both caspase-3 and PARP-1 and partially restored differentiation (decrease of Ki67 marker). Our findings highly support the use of siRNAs-SQ NPs as a treatment for patients affected by PTC expressing RET/PTCs.
22

Rôle du système générateur d’espèces réactives de l’oxygène NOX4-p22phox dans la thyroïde humaine : implication dans la prolifération et la différenciation thyroïdienne / Role of the NOX4-p22phox ROS Producing System in the Human Thyroid : Implication in Thyroid Proliferation and Differenciation

Cailloux, Jérémy 17 November 2014 (has links)
Rôle de la NADPH oxydase NOX4 dans la régulation de l'expression du symporteur sodium/iode (NIS) dans le cas du cancer papillaire de la thyroïde (PTC). L’activation autocrine de la voie TGF-β induite par BRAFV600E régule négativement l’expression du symporteur sodium/iode (NIS) via une production de ROS dépendante de la NOX4 dans le cancer papillaire de la thyroïde. Résumé : Le cancer papillaire de la thyroïde (PTC) est la pathologie thyroïdienne la plus répandue. Les mutations ponctuelles de BRAF sont retrouvées dans 40 à 60 % des cas de PTC. La transversion BRAFT1799A est la mutation de BRAF la plus fréquente. Les tumeurs porteuses de la mutation BRAFV600E sont souvent associées avec une diminution significative de l’expression du transporteur sodium/iode (NIS). Les résultats cliniques sur les patients atteints d’un cancer de la thyroïde porteur de la mutation BRAFV600E ont montré que l’inhibition de la voie MAPK ne permet pas de rétablir de manière assez importante l’expression du NIS induite par BRAFV600E. L’expression de BRAFV600E induit la sécrétion de TGF-β fonctionnel, qui inhibe l’expression des protéines thyroïdiennes impliquées dans le métabolisme de l’iode, et particulièrement le NIS. La NOX4 est surexprimée dans un nombre croissant de tumeurs, et particulièrement dans les cas de PTC. Dans le cas du cancer du sein, les mécanismes critiques pour le développement du cancer impliquent la régulation par le TGF-β de la NOX4 au niveau transcriptionnel via le facteur de transcription Smad3. Ces données nous mènent à considérer la NOX4 comme un candidat sérieux pour le rôle de système générateur de ROS contrôlé par la boucle autocrine TGF-β induite par BRAFV600E. Dans cette étude, nous avons tout d’abord observé une corrélation entre la présence de l’oncogène BRAFV600E, la surexpression de la NOX4 et l’inhibition de l’expression du NIS dans les cancers papillaires de la thyroïde. Puis, en utilisant la lignée BCPAP comme modèle in vitro de PTC, nous avons démontré BRAFV600E contrôle l’expression de la NOX4 et de la p22phox par l’intermédiaire de la signalisation TGF-β/Smads. La boucle TGF-β induite par BRAFV600E induit l’expression de la NOX4 et de la p22phox au niveau transcriptionnel via phosphorylated SMAD3. L’expression constitutive de la NOX4 et de la p22phox, qui forment ensemble un complexe NADPH oxydase fonctionnel, contribue au stress oxydatif observé dans les cellules BCPAP. Le traitement des cellules BCPAP par des scavengers de ROS comme le N-acetyl cysteine (NAC) et le Tiron permettent d’augmenter l’expression du NIS au niveau transcriptionnel et de rétablir l’expression d’une protéine fonctionnelle permettant la captation d’iode, ce qui indique que les ROS sont impliqués dans l’inhibition de l’expression du NIS. L’inhibition spécifique de la NOX4 par siRNA permet de réinduire l’expression de l’ARN messager et de la protéine NIS. Ces résultats montrent pour la première fois que les ROS produits par la NOX4 jouent un rôle critique dans l’inhibition de l’expression du NIS induite par BRAFV600E via la signalisation TGF-β/SMAD3. / BRAFV600E induced-TGF-β secretion down-regulates sodium iodide symporter (NIS) expression via NOX4-dependent ROS generation in papillary thyroid carcinoma. Abstract : Papillary thyroid cancer (PTC) is the most common thyroid pathology and BRAF point mutations account for 40-60% of tumors. BRAFT1799A is the most frequent BRAF mutation and BRAFV600E positive tumors are often associated with a significant loss of sodium/iodide symporter (NIS) expression. Clinical results on patients harboring thyroid cancer with BRAF mutation have recently shown that MAPK pathway inhibition does not fully reverts the BRAF-induced NIS repression. BRAFV600E expression induces secretion of functional TGF-β which is a repressor of thyroid specific genes such as NIS. Importantly, NOX4 has been shown to be prominently expressed in an increasing number of tumors, in particular in PTCs. In breast cancer cells, a critical mechanism for cancer development involves the transcriptional regulation of NOX4 by TGF-β. This result prompted us to test NOX4 as a ROS-producing candidate induced by BRAF-induced TGF-β. In this report, we first show in PTCs a correlation between BRAFV600E status, NOX4 overexpression, and low NIS expression level. Then, using BCPAP cells as an in vitro PTC model, we demonstrate that BRAFV600E controls NOX4 and p22phox expression via TGF-β signalling. The TGF-β autocrine loop activated by BRAFV600E induces NOX4 and p22phox expression at the transcriptional level via phosphorylated SMAD3. Both constitutively expressed proteins form a functional NADPH oxidase which produces high intracellular ROS levels. ROS scavengers increase the NIS expression at both mRNA and protein levels, and rescue a functional NIS, indicating that ROS are involved in the repression of NIS. Knocking down NOX4 with specific siRNAs reinduces NIS expression at both mRNA and protein levels. Altogether, these results show for the first time that NOX4-dependent ROS generation has a critical role in BRAF-induced NIS repression via the TGF-β/SMAD3 oncogenic signalling.
23

Influência do MicroRNA let-7 e miR-17-92 como oncomiRs no câncer. / Influence of MicroRNA let-7 and miR-17-92 as oncomiRs in cancer.

Fuziwara, Cesar Seigi 24 August 2010 (has links)
No câncer, alterações em microRNAs (miRNAs), pequenos RNAs que regulam a tradução protéica, exerce efeito oncogênico (oncomiR). Os oncomiRs regulam genes chave para a proliferação celular e apoptose, sendo importantes para a biologia do câncer. O carcinoma papilífero de tiróide apresenta alterações genéticas alinhadas na via MAPK (RET>RAS>BRAF>ERK). Observamos que a indução do oncogene RET/PTC diminui a expressão de let-7 em células foliculares tiroidianas. Na linhagem TPC-1 (com RET/PTC-1), a introdução de let-7 diminui a proliferação celular e a fosforilaçãode ERK, indicando papel de gene supressor tumoral. No carcinoma anaplásico, avaliamos o papel da introdução do cluster miR-17-92 na linhagem ARO. Observamos que in vitro miR-17-92 atua de forma oncogênica aumentando proliferação e viabilidade celular de ARO. No entanto, estas células apresentam diminuição no crescimento em soft-agar. No xenotransplante, os tumores de ARO-miR-17-92 apresentam menor volume e expressam MMP-9 de forma reduzida, indicando também um papel de gene supressor tumoral para o cluster. / In cancer, alteration in microRNA, small RNAs (~22nt) that regulate post-transcriptionally protein levels, exerts oncogenic role (oncomiR). OncomiRs control genes involved in cell proliferation and apoptosis, influencing cancer biology. Papillary thyroid cancer displays activating genetic alterations in MAPK signaling pathway (RET>RAS>BRAF>ERK). Using conditional induction of oncogenes in thyroid cells, we observed that RET/PTC decreases let-7 miRNA expression. In papillary thyroid cancer cell TPC-1 (with RET/PTC-1) we observed that let-7 introduction inhibits cell proliferation and ERK phosphorylation, indicating tumor suppressor role for let-7. In anaplastic thyroid cancer, we evaluate the role of introduction of miR-17-92 cluster in ARO cell line. We observed in vitro that miR-17-92 increases ARO cell proliferation and viability, acting as oncogene. However, these cells show impaired soft agar growth. In xenotransplant, ARO-miR-17-92 tumors are smaller in volume and express reduced levels of MMP-9, indicating a tumor suppressor role for the cluster.
24

Influência do MicroRNA let-7 e miR-17-92 como oncomiRs no câncer. / Influence of MicroRNA let-7 and miR-17-92 as oncomiRs in cancer.

Cesar Seigi Fuziwara 24 August 2010 (has links)
No câncer, alterações em microRNAs (miRNAs), pequenos RNAs que regulam a tradução protéica, exerce efeito oncogênico (oncomiR). Os oncomiRs regulam genes chave para a proliferação celular e apoptose, sendo importantes para a biologia do câncer. O carcinoma papilífero de tiróide apresenta alterações genéticas alinhadas na via MAPK (RET>RAS>BRAF>ERK). Observamos que a indução do oncogene RET/PTC diminui a expressão de let-7 em células foliculares tiroidianas. Na linhagem TPC-1 (com RET/PTC-1), a introdução de let-7 diminui a proliferação celular e a fosforilaçãode ERK, indicando papel de gene supressor tumoral. No carcinoma anaplásico, avaliamos o papel da introdução do cluster miR-17-92 na linhagem ARO. Observamos que in vitro miR-17-92 atua de forma oncogênica aumentando proliferação e viabilidade celular de ARO. No entanto, estas células apresentam diminuição no crescimento em soft-agar. No xenotransplante, os tumores de ARO-miR-17-92 apresentam menor volume e expressam MMP-9 de forma reduzida, indicando também um papel de gene supressor tumoral para o cluster. / In cancer, alteration in microRNA, small RNAs (~22nt) that regulate post-transcriptionally protein levels, exerts oncogenic role (oncomiR). OncomiRs control genes involved in cell proliferation and apoptosis, influencing cancer biology. Papillary thyroid cancer displays activating genetic alterations in MAPK signaling pathway (RET>RAS>BRAF>ERK). Using conditional induction of oncogenes in thyroid cells, we observed that RET/PTC decreases let-7 miRNA expression. In papillary thyroid cancer cell TPC-1 (with RET/PTC-1) we observed that let-7 introduction inhibits cell proliferation and ERK phosphorylation, indicating tumor suppressor role for let-7. In anaplastic thyroid cancer, we evaluate the role of introduction of miR-17-92 cluster in ARO cell line. We observed in vitro that miR-17-92 increases ARO cell proliferation and viability, acting as oncogene. However, these cells show impaired soft agar growth. In xenotransplant, ARO-miR-17-92 tumors are smaller in volume and express reduced levels of MMP-9, indicating a tumor suppressor role for the cluster.
25

PEX1 Mutations in Australasian Patients with Disorders of Peroxisome Biogenesis

Maxwell, Megan Amanda, n/a January 2004 (has links)
The peroxisome is a subcellular organelle that carries out a diverse range of metabolic functions, including the b-oxidation of very long chain fatty acids, the breakdown of peroxide and the a-oxidation of fatty acids. Disruption of peroxisome metabolic functions leads to severe disease in humans. These diseases can be broadly grouped into two categories: those in which a single enzyme is defective, and those known as the peroxisome biogenesis disorders (PBDs), which result from a generalised failure to import peroxisomal matrix proteins (and consequently result in disruption of multiple metabolic pathways). The PBDs result from mutations in PEX genes, which encode protein products called peroxins, required for the normal biogenesis of the peroxisome. PEX1 encodes an AAA ATPase that is essential for peroxisome biogenesis, and mutations in PEX1 are the most common cause of PBDs worldwide. This study focused on the identification of mutations in PEX1 in an Australasian cohort of PBD patients, and the impact of these mutations on PEX1 function. As a result of the studies presented in this thesis, twelve mutations in PEX1 were identified in the Australasian cohort of patients. The identified mutations can be broadly grouped into three categories: missense mutations, mutations directly introducing a premature termination codon (PTC) and mutations that interrupt the reading frame of PEX1. The missense mutations that were identified were R798G, G843D, I989T and R998Q; all of these mutations affect amino acid residues located in the AAA domains of the PEX1 protein. Two mutations that directly introduce PTCs into the PEX1 transcript (R790X and R998X), and four frameshift mutations (A302fs, I370fs, I700fs and S797fs) were identified. There was also one mutation found in an intronic region (IVS22-19A>G) that is presumed to affect splicing of the PEX1 mRNA. Three of these mutations, G843D, I700fs and G973fs, were found at high frequency in this patient cohort. At the commencement of these studies, it was hypothesised that missense mutations would result in attenuation of PEX1 function, but mutations that introduced PTCs, either directly or indirectly, would have a deleterious effect on PEX1 function. Mutations introducing PTCs are thought to cause mRNA to be degraded by the nonsense-mediated decay of mRNA (NMD) pathway, and thus result in a decrease in PEX1 protein levels. The studies on the cellular impact of the identified PEX1 mutations were consistent with these hypotheses. Missense mutations were found to reduce peroxisomal protein import and PEX1 protein levels, but a residual level of function remained. PTC-generating mutations were found to have a major impact on PEX1 function, with PEX1 mRNA and protein levels being drastically reduced, and peroxisomal protein import capability abolished. Patients with two missense mutations showed the least impact on PEX1 function, patients with two PTC-generating mutations had a severe defect in PEX1 function, and patients carrying a combination of a missense mutation and a PTC-generating mutation showed levels of PEX1 function that were intermediate between these extremes. Thus, a correlation between PEX1 genotype and phenotype was defined for the Australasian cohort of patients investigated in these studies. For a number of patients, mutations in the coding sequence of one PEX1 allele could not be identified. Analysis of the 5' UTR of this gene was therefore pursued for potential novel mutations. The initial analyses demonstrated that the 5' end of PEX1 extended further than previously reported. Two co-segregating polymorphisms were also identified, termed –137 T>C and –53C>G. The -137T>C polymorphism resided in an upstream, in-frame ATG (termed ATG1), and the possibility that the additional sequence represented PEX1 coding sequence was examined. While both ATGs were found to be functional by virtue of in vitro and in vivo expression investigations, Western blot analysis of the PEX1 protein in patient and control cell extracts indicated that physiological translation of PEX1 was from the second ATG only. Using a luciferase reporter approach, the additional sequence was found to exhibit promoter activity. When examined alone the -137T>C polymorphism exerted a detrimental effect on PEX1 promoter activity, reducing activity to half that of wild-type levels, and the -53C>G polymorphism increased PEX1 promoter activity by 25%. When co-expressed (mimicking the physiological condition) these polymorphisms compensated for each other to bring PEX1 promoter activity to near wild-type levels. The PEX1 mutations identified in this study have been utilised by collaborators at the National Referral Laboratory for Lysosomal, Peroxisomal and Related Genetic Disorders (based at the Women's and Children's Hospital, Adelaide), in prenatal diagnosis of the PBDs. In addition, the identification of three common mutations in Australasian PBD patients has led to the implementation of screening for these mutations in newly referred patients, often enabling a precise diagnosis of a PBD to be made. Finally, the strong correlation between genotype and phenotype for the patient cohort investigated as part of these studies has generated a basis for the assessment of newly identified mutations in PEX1.
26

Optimalizace pohybu termoelektrického lineárního aktuátoru / Movement optimization of the thermoelectric linear actuator

Belháč, Jakub January 2011 (has links)
The thesis describes movement optimization of a linear thermoelectric actuator that is used for operating floor heating valves in modern buildings. Featuring experimental nature, the thesis deals with a problem specified by an industrial company within the following steps; definition of possible solutions based on problem research, experimental verification of selected propositions, the best solution selection resulting from the analysis of executed measurements, final verification with all product versions, benchmarking.
27

PTC Mathcad Prime : Überblick / PTC Mathcad Prime : overview

Wüst, Michael, Förster, Steffen 08 May 2014 (has links) (PDF)
Einsatzmöglichkeiten, Neuheiten und Ausblick auf kommende Releases von Mathcad Prime
28

PTC CREO SIMULATE ENGINE UPDATES

Chavan, Arun T. 06 June 2017 (has links) (PDF)
This presentation is intended to inform about news of Creo Simulate.
29

Targeted Inhibition of Polycomb Repressive Complexes in Multiple Myeloma : Implications for Biology and Therapy

Alzrigat, Mohammad January 2017 (has links)
Multiple myeloma (MM) is a hematological malignancy of antibody producing plasmablasts/plasma cells. MM is characterized by extensive genetic and clonal heterogeneity, which have hampered the attempts to identify a common underlying mechanism for disease establishment and development of appropriate treatment regimes. This thesis is focused on understanding the role of epigenetic regulation of gene expression mediated by the polycomb repressive complexes 1 and 2 (PRC1 and 2) in MM and their impact on disease biology and therapy. In paper I the genome-wide distribution of two histone methylation marks; H3K27me3 and H3K4me3 were studied in plasma cells isolated from newly diagnosed MM patients or age-matched normal donors. We were able to define targets of H3K27me3, H3K4me3 and bivalent (carry both marks) which are, when compared to normal individuals, unique to MM patients. The presence of H3K27me3 correlated with silencing of MM unique H3K27me3 targets in MM patients at advanced stages of the disease. Notably, the expression pattern of H3K27me3-marked genes correlated with poor patient survival. We also showed that inhibition of the PRC2 enzymatic subunit EZH2 using highly selective inhibitors (GSK343 and UNC1999) demonstrated anti-myeloma activity using relevant in vitro models of MM. These data suggest an important role for gene repression mediated by PRC2 in MM, and highlights the PRC2 component EZH2 as a potential therapeutic target in MM. In paper II we further explored the therapeutic potential of UNC1999, a highly selective inhibitor of EZH2 in MM. We showed that EZH2 inhibition by UNC1999 downregulated important MM oncogenes; IRF-4, XBP-1, BLIMP-1and c-MYC. These oncogenes have been previously shown to be crucial for disease establishment, growth and progression. We found that EZH2 inhibition reactivated the expression of microRNAs genes previously found to be underexpressed in MM and which possess potential tumor suppressor functions. Among the reactivated microRNAs we identified miR-125a-3p and miR-320c as predicted negative regulators of the MM-associated oncogenes. Notably, we defined miR-125a-3p and miR-320c as targets of EZH2 and H3K27me3 in MM cell lines and patients samples.  These findings described for the first time PRC2/EZH2/H3K27me3 as regulators of microRNA with tumor suppressor functions in MM. This further strengthens the oncogenic features of EZH2 and its potential as a therapeutic target in MM. In paper III we evaluated the therapeutic potential of targeting PRC1 in MM using the recently developed chemical PTC-209; an inhibitor targeting the BMI-1 subunit of PRC1. Using MM cell lines and primary cells isolated from newly diagnosed or relapsed MM patients, we found that PTC-209 has a potent anti-MM activity. We showed, for the first time in MM, that PTC-209 anti-MM effects were mediated by on-target effects i.e. downregulation of BMI-1 protein and the associated repressive histone mark H2AK119ub, but that other subunits of the PRC1 complex were not affected. We showed that PTC-209 reduced MM cell viability via significant induction of apoptosis. More importantly, we demonstrated that PTC-209 shows synergistic anti-MM activity with other epigenetic inhibitors targeting EZH2 (UNC1999) and BET-bromodomains (JQ1). This work highlights the potential use of BMI-1 and PRC1 as potential therapeutic targets in MM alone or in combination with other anti-MM agents including epigenetic inhibitors.
30

Modélisation et simulation sociale pour l'évaluation de l'empuissancement par des politiques publiques dans les territoires ruraux au Brésil / Social modeling and simulation for assessing empowerment through public policies in rural territories in Brazil

Santos Da Silva, Marcos Aurélio 11 June 2019 (has links)
Le Brésil a initié deux politiques publiques territoriales pour le développement rural durable, le Programme National pour le Développement Durable des Territoires Ruraux (PRONAT) et le Programme Territoires de la Citoyenneté (PTC). Ces politiques s’appliquent dans des Territoires Ruraux et visent entre autre, comme condition de leur effectivité, à ré-équilibrer les rapports de forces entre les acteurs au sein de la Collégialité pour le Développement Territorial (CODETER) de chaque Territoire Rural. Notre recherche étudie l’hypothèse selon laquelle, dans les Territoires Ruraux soumis aux politiques publiques PRONAT et PTC, les rapports de pouvoir et de réciprocité entre les acteurs engagés dans les CODETER ont effectivement évolué, en faveur des représentants de la société civile et au détriment des pouvoirs publics établis, notamment les mairies. Cette recherche a développé une méthode de modélisation et de simulation des relations de pouvoir et de réciprocité au sein des entités territoriales. Nous partons de l’idée que les processus sociaux territorialisés donnent lieu à des phénomènes complexes qu’il est pertinent d’appréhender par l’approche systémique. Cela nous conduit à proposer un modèle conceptuel des territoires ruraux considérés par les politiques publiques brésiliennes en matière de développement durable territorialisée, à savoir le concept de système socioterritorial complexe, puis à considérer les théories des sciences sociales qui peuvent être mobilisées pour étayer la représentation de ces systèmes sous la forme computationnelle de sociétés artificielles. Nous avons évalué deux courants sociologiques, l’individualisme méthodologie associé à la rationalité limitée à partir de la Sociologie de l’Action Organisée, et les Systèmes Sociaux de Luhmann plus attachés à la théorie de la complexité. Nous avons développé un métamodèle de la théorie luhmannienne qui s’avère insuffisant pour analyser l’impact des politiques publiques sur le territoire, mais qui peut être vu comme un outil pour la validation de la théorie de Luhmann. D’autre part, nous avons adopté le métamodèle SocLab, une formalisation computationnelle de la Sociologie de l’Action Organisée, pour modéliser, analyser et simuler les systèmes socioterritoriaux complexes. Pour évaluer les effets des politiques publiques sur les échanges symboliques entre les acteurs dans un modèle SocLab, nous proposons un indicateur, le taux de réciprocité, basé sur la théorie de la réciprocité. Cette démarche a été appliquée à l’étude de deux terrains, le Territoire Rural Sud de Sergipe et le Territoire Rural du Bas São Francisco. Les données nécessaires à l’élaboration d’un modèle SocLab ont été collectées par l’analyse documentaire et la recherche-action pour deux périodes de référence, 2008-2012 et 2013-2017. À partir de l’étude analytique des modèles SocLab des deux territoires et de l’analyse des résultats de leur simulation (notamment la capacité d’action, le pouvoir et le taux de réciprocité), nous pouvons dégager des évidences pour affirmer que les politiques publiques PRONAT et PTC ont donné lieu, entre les deux périodes considérées, à un nouvel équilibre des rapports de forces entre les représentants de la société civile et les pouvoirs publics. L’approche SocLab s’est avérée effective pour systématiser la connaissance sur les territoires, mettre en évidence la structure sociale informelle, quantifier les relations d’échanges symboliques entre les acteurs, et pour tester différentes hypothèses sociologiques. / Brazil has initiated two territorial public policies for a rural sustainable development, the National Program for Sustainable Development of the Rural Territories (PRONAT) and Citizenship Territory Program (PTC). These public policies aims, as a condition for its effectiveness, the equilibrium of the power relations between actors which participate in the Collegiate for Territorial Development (CODETER) of each Rural Territory. Our research studies the hypotheses that, in the Rural Territories submitted to the PRONAT and PTC public policies, the power and reciprocity relations between actors engaged in the CODETER effectively have evolved in favor of the civil society representatives to the detriment of the public powers, notably the mayors. This research has developed a method for modeling and simulation of power and reciprocity relations in the Rural Territories to assess the impact of the public policies for local development (PRONAT and PTC). We have started from the idea that the territorialized social processes are complex phenomena which can be understood by the systemic approach. This induced us to propose a conceptual model of rural territories considered by Brazilian public policies in terms of territorialized sustainable development, the concept of socioterritorial complex system, as they were established by the Brazilians public policies with focus on territorial sustainable development. Then, to consider the theories of social sciences which can be mobilized to support the representation of these systems in the computational form of artificial societies. We evaluated two sociological currents, the methodological individualism associated with the bounded rationality from the Sociology of the Organized Action, and the Luhmann’s Social Systems more attached to the complexity theory. We have developed a metamodel of the luhmannian theory that showed to be limited to the analyses of the impact of the territorial public policies, but it can be seen as a tool to instantiate parts of the Luhmann theory. On the other hand, we have adopted the metamodel SocLab, a computational formalization of the Sociology of the Organized Action, to model, analyze and simulate complex socio-territorial systems. To evaluate the effects of the public policies on the symbolic exchanges between actors in a SocLab model, we have proposed an indicator, the reciprocity rate, based on the reciprocity theory. This approach has been applied in two case studies, the Southern Rural Territory of Sergipe and the São Francisco Rural Territory. The data needed to design the SocLab models were collected using literature review and performing action-research for two referential periods, 2008-2012 and 2013-2017. From the analytic study of the SocLab models of the two territories and the analysis of the results of their simulation (notably the capacity of action, the power and the rate of reciprocity), we can draw evidences to states that the public policies PRONAT and PTC resulted in a new balance of power relations between representatives of civil society and the public authorities between the two periods under review. The SocLab approach showed a strong effectiveness to systematize the knowledge about the territories, highlighting the informal social structure, quantifying symbolic exchange relations between actors, and testing different sociological hypotheses. / O Brasil iniciou duas políticas públicas territoriais para o desenvolvimento sustentável, o Programa Nacional para o Desenvolvimento Sustentável de Territórios Rurais (PRONAT) e o Programa Territórios da Cidadania (PTC). Estas políticas públicas se aplicam aos Territórios Rurais e visam entre outros objetivos, como condição de sua efetividade, o equilíbrio das relações de força entre os atores que participam do Colegiado de Desenvolvimento Territorial (CODETER) de cada Território Rural. Nossa pesquisa estuda a hipótese segundo a qual, nos Territórios Rurais submetidos às políticas públicas PRONAT e PTC, as relações de poder e reciprocidade entre os atores engajados no CODETER efetivamente evoluíram em favor dos representantes da sociedade civil em detrimento dos poderes públicos, notadamente dos prefeitos. Esta pesquisa desenvolveu um método de modelagem e simulação das relações de poder e reciprocidade dentros das entidades territoriais. Nós partimos da ideia de que os processos sociais territorialisados são fenômenos complexos que podem ser compreendidos pela abordagem sistêmica. Isto nos conduziu a propor um modelo conceitual de territórios rurais, o conceito de sistema socioterritorial complexo, assim como eles são estabelecidos pelas políticas públicas brasileiras com enfoque de desenvolvimento territorial sustentável, depois consideramos as teorias oriundas das ciências sociais que podem ser utilizadas para sustentar a representação desses sistemas sob a forma computacional de sociedades artificiais. Avaliamos duas correntes sociológicas, o individualismo metodológico associado à racionalidade limitada a partir da Sociologia da Ação Organizada, e os Sistemas Sociais de Luhmann mais relacionados à teoria da complexidade. Desenvolvemos um metamodelo da teoria luhmanniana que se mostrou insuficiente para a análise do impacto de políticas públicas territoriais, mas que pode ser visto como uma ferramenta para validação da teoria de Luhmann. Por outro lado, adotamos o metamodelo SocLab, uma formalização computacional da Sociologia da Ação Organizada, para modelar os sistemas sociais complexos. Para avaliar os efeitos das políticas públicas sobre as trocas simbólicas entre os atores no contexto SocLab nós propomos um indicador, a taxa de reciprocidade, baseado na teoria da reciprocidade. Esta abordagem foi aplicada a dois estudos de caso, o Território Rural Sul Sergipano e o Território Rural Baixo São Francisco. Os dados necessários para a elaboração dos modelos SocLab foram coletados por análise documental e por pesquisa-ação para dois períodos de referência, 2008-2012 e 2013-2017. A partir do estudo analítico e da análise dos resultados das simulações dos modelos SocLab dos dois territórios (notadamente a capacidade de ação, o poder e a taxa de reciprocidade), nos podemos retirar evidências para afirmar que as políticas públicas PRONAT e PTC deram origem, entre os dois períodos considerados, a um novo equilíbrio de relações de força entre os representantes da sociedade civil e os poderes públicos. A abordagem SocLab demonstrou bastante efetividade para sistematizar o conhecimento sobre os territórios, colocar em evidência a estrutura social informal, quantificar as relações de trocas simbólicas entre os atores, e também para testar hipóteses sociológicas.

Page generated in 0.214 seconds